Sarcopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 60 years (elderly), gender not restricted. 2. Diagnosed with sarcopenia according to the Asian Working Group for Sarcopenia (AWGS 2019) criteria: manifested by low muscle strength (male grip strength < 28 kg, female < 18 kg) and reduced muscle mass (male limb skeletal muscle mass index < 7.0 kg/m^2, female < 5.7 kg/m^2, measured by bioelectrical impedance analysis; or equivalent degree of muscle reduction measured by dual-energy X-ray absorptiometry), with or without decline in physical function (such as walking speed < 1.0 m/s or Simple Physical Status Scale score = 9). Patients with "suspected sarcopenia" who meet the muscle strength criteria (only having low muscle strength but not reaching the muscle mass reduction criteria) also meet the inclusion criteria, as early intervention is still considered to have clinical benefits. 3. Evaluated by a physician to have the ability to move (able to use assistive devices) and be able to participate in the exercise program (i.e., without uncontrolled diseases that affect exercise). 4. Obtained a medical permission from a primary care physician or research physician to "participate in a moderate-intensity exercise program". 5. Normal cognitive function, able to sign the informed consent form and follow the research guidelines (such as no moderate to severe dementia). 6. Voluntarily accept random grouping to any exercise program and promise to follow the research process (including follow-up arrangements).
Exclusion criteria
Exclusion criteria: 1. There are severe cardiovascular, pulmonary or orthopedic diseases that make exercise impossible or pose safety risks (for example: recent myocardial infarction, uncontrolled angina pectoris, severe chronic obstructive pulmonary disease, uncontrolled hypertension, advanced arthritis severely affecting mobility). 2. Suffer from acute diseases or injuries that may interfere with participation in the exercise (for example: acute fractures, recovery period within 3 months after surgery). 3. Have neurological or mental disorders that may affect participation ability or safety (for example: Parkinson's disease accompanied by gait instability, uncontrolled epileptic seizures, severe depression with suicidal tendencies). 4. Have participated in other interventional clinical trials or structured exercise programs within the past 3 months (to avoid confounding effects). 5. Live in a nursing home or long-term care facility (this study is targeted at community-dwelling individuals; the institutional care environment may affect result assessment due to differences in care). 6. The investigator determines that there are any circumstances that make participation in the trial inappropriate (for example: unable to participate in outdoor courses due to transportation issues, environmental allergies, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of the Profile of Mood States (POMS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Rosenberg Self-Esteem Scale (RSE);Perceived Stress Scale (PSS, 10-item version);SF-36 Scale; | — |
Countries
China
Contacts
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine